Literature DB >> 20810614

Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.

Xiaoyan Wang1, Fengmin Li, Pedro A Jose, Carolyn M Ecelbarger.   

Abstract

Dopamine produced by renal proximal tubules increases sodium excretion via a decrease in renal sodium reabsorption. Dopamine natriuresis is impaired in obese Zucker rats; however, the mechanism is not fully understood. To test the hypothesis that renal expression of one or more of the subtypes are altered in these rats, we measured whole kidney protein levels by immunoblotting of D1-like (D1R and D5R) and D2-like (D2R, D3R, and D4R) dopamine receptors in both male and female obese and lean Zucker rats. In obese males on 1% NaCl diet, D1R, D2R, D4R, and D5R were decreased, while D3R was increased, relative to lean rats. Under a 4% NaCl diet, D2R and D3R levels in obese rats were restored to lean levels. 4% NaCl diet reduced D5R in both body types, relative to 1% NaCl diet. Female rats had higher expression of D1R and D3R than did male; however, the sex difference for D1R was markedly blunted in obese rats. In obese rats, dietary candesartan (angiotensin II type 1 receptor blocker) normalized downregulated D1R and D2R, but either decreased (D3R), did not affect (D4R), or further downregulated (D5R) the other subtypes. Candesartan also decreased D4R in lean rats. In summary, reduced renal protein levels of D1R, D2R, D4R, and D5R in obese Zucker rats could induce salt sensitivity and elevate blood pressure. Increased angiotensin II type 1 receptor activity may be mechanistically involved in the decreased expression of D1R and D2R in obese rats. Finally, reduced D1R and D3R in male rats may contribute to sex differences in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810614      PMCID: PMC2980410          DOI: 10.1152/ajprenal.00604.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

1.  Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade.

Authors:  Zhong-Gao Xu; Linda Lanting; Nosratola D Vaziri; Zhen Li; Lili Sepassi; Bernardo Rodriguez-Iturbe; Rama Natarajan
Journal:  Circulation       Date:  2005-04-19       Impact factor: 29.690

Review 2.  Metabolic syndrome: therapeutic considerations.

Authors:  S M Grundy
Journal:  Handb Exp Pharmacol       Date:  2005

3.  D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure.

Authors:  Zhiwei Yang; Laureano D Asico; Peiying Yu; Zheng Wang; John E Jones; Crisanto S Escano; Xiaoyan Wang; Mark T Quinn; David R Sibley; Guillermo G Romero; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

4.  Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes.

Authors:  Marie-Luise P Gross; Andreas Koch; Bernd Mühlbauer; Marcin Adamczak; Heike Ziebart; Karla Drescher; Gerhard Gross; Irina Berger; Kerstin U Amann; Eberhard Ritz
Journal:  Lab Invest       Date:  2006-03       Impact factor: 5.662

5.  Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats.

Authors:  Anees Ahmad Banday; Aditi Marwaha; Lakshmi S Tallam; Mustafa F Lokhandwala
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

6.  Altered dopamine D2 receptor function and binding in obese OLETF rat.

Authors:  Andras Hajnal; Wojciech M Margas; Mihai Covasa
Journal:  Brain Res Bull       Date:  2007-08-08       Impact factor: 4.077

7.  Sex differences in renal nitric oxide synthase, NAD(P)H oxidase, and blood pressure in obese Zucker rats.

Authors:  Shahla Riazi; Veerendra K Madala-Halagappa; Ana Paula Dantas; Xinqun Hu; Carolyn A Ecelbarger
Journal:  Gend Med       Date:  2007-09

8.  Arterial blood pressure and renal sodium excretion in dopamine D3 receptor knockout mice.

Authors:  Torsten Staudacher; Bärbel Pech; Michael Tappe; Gerhard Gross; Bernd Mühlbauer; Gerd Luippold
Journal:  Hypertens Res       Date:  2007-01       Impact factor: 3.872

9.  Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.

Authors:  Hewang Li; Ines Armando; Peiying Yu; Crisanto Escano; Susette C Mueller; Laureano Asico; Annabelle Pascua; Quansheng Lu; Xiaoyan Wang; Van Anthony M Villar; John E Jones; Zheng Wang; Ammasi Periasamy; Yuen-Sum Lau; Patricio Soares-da-Silva; Karen Creswell; Gaétan Guillemette; David R Sibley; Gilbert Eisner; John J Gildea; Robin A Felder; Pedro A Jose
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.

Authors:  Veerendra K Madala Halagappa; Swasti Tiwari; Shahla Riazi; Xinqun Hu; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-27
View more
  11 in total

1.  Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.

Authors:  Shilin Yang; Bing Yao; Yunfeng Zhou; Huiyong Yin; Ming-Zhi Zhang; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

2.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

Review 3.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

4.  Transcriptional regulation of renal dopamine D1 receptor function during oxidative stress.

Authors:  Anees A Banday; Mustafa F Lokhandwala
Journal:  Hypertension       Date:  2015-03-02       Impact factor: 10.190

Review 5.  Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease.

Authors:  Robin A Felder; John J Gildea; Peng Xu; Wei Yue; Ines Armando; Robert M Carey; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2022-06-16       Impact factor: 4.592

6.  Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.

Authors:  Xiaoyan Wang; Crisanto S Escano; Laureano Asico; John E Jones; Alan Barte; Yuen-Sum Lau; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

Review 7.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

Review 8.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

9.  Dopamine D5 receptor-mediated decreases in mitochondrial reactive oxygen species production are cAMP and autophagy dependent.

Authors:  Hewang Lee; Xiaoliang Jiang; Imran Perwaiz; Peiying Yu; Jin Wang; Ying Wang; Maik Hüttemann; Robin A Felder; David R Sibley; Brian M Polster; Selim Rozyyev; Ines Armando; Zhiwei Yang; Peng Qu; Pedro A Jose
Journal:  Hypertens Res       Date:  2021-04-05       Impact factor: 5.528

10.  Inactivation of Cys674 in SERCA2 increases BP by inducing endoplasmic reticulum stress and soluble epoxide hydrolase.

Authors:  Gang Liu; Fuhua Wu; Xiaoli Jiang; Yumei Que; Zhexue Qin; Pingping Hu; Kin Sing Stephen Lee; Jian Yang; Chunyu Zeng; Bruce D Hammock; Xiaoyong Tong
Journal:  Br J Pharmacol       Date:  2020-01-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.